Australia markets open in 7 hours

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.79+0.07 (+0.45%)
As of 12:58PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.22B
Enterprise value 997.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.88
Enterprise value/revenue 2.53k
Enterprise value/EBITDA -19.49

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-30.43%
S&P500 52-week change 323.06%
52-week high 323.81
52-week low 311.83
50-day moving average 316.49
200-day moving average 316.98

Share statistics

Avg vol (3-month) 3438.45k
Avg vol (10-day) 3455.93k
Shares outstanding 577.45M
Implied shares outstanding 648.09M
Float 8440.24M
% held by insiders 14.28%
% held by institutions 184.83%
Shares short (28 Mar 2024) 46.56M
Short ratio (28 Mar 2024) 415.5
Short % of float (28 Mar 2024) 48.46%
Short % of shares outstanding (28 Mar 2024) 48.10%
Shares short (prior month 29 Feb 2024) 46.34M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-14.64%
Return on equity (ttm)-22.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -65.79M
Net income avi to common (ttm)-54.37M
Diluted EPS (ttm)-0.72
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)271.77M
Total cash per share (mrq)0.42
Total debt (mrq)51.33M
Total debt/equity (mrq)20.59%
Current ratio (mrq)33.33
Book value per share (mrq)3.10

Cash flow statement

Operating cash flow (ttm)-50.22M
Levered free cash flow (ttm)-36.63M